|
 |
PRODUCT
The page is no longer available. You may want to read the following pages.
MR Carnethon, B Sternfeld, K Liu... - Medicine & Science ..., 2011 - Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining
your privacy and will not share your personal information without your express consent. For more
information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ...
H Kaneko... - Circulation Journal, 2011 - ; In the past, coronary artery bypass graft surgery has been applied to revascularization for unprotected left main coronary artery (ULMCA) disease. In recent years, due to the advent of drug-eluting stents (DES), restenosis rates have decreased in comparison to ...
E Bode, T Wuppinger, T Bode, H Alber... - Coronary Artery ..., 2011 - Objective: The aim of the study was to compare N-terminal pro B-type natriuretic peptide (NT-pro BNP), high-sensitivity C-reactive protein, and gamma-glutamyl transferase ([gamma]-GT) with traditional risk markers for estimating prognosis in patients with stable coronary artery ...
DM Zlotnick... - Annals of Internal Medicine, 2012 - Am Coll Physicians Background: Sudafed PE (Mc Neil-PPC, Fort Washington, Pennsylvania) contains phenylephrine, whose predominant mechanism is to directly stimulate α-adrenergic receptors, leading to vasoconstriction. This medication can potentiate arrhythmia, ... [CITATION] Prevalence of Fabry Disease in a High Risk US Cohort with Hypertophic Cardiomyopathy and Other Cardiac Diagnoses K Goss, M Taylor, M Maron, B Maron... - Molecular Genetics and ..., 2012 - Elsevier
M Geene, F Tuncay, P Borman, D Ycel... - ..., 2012 - Br Soc Rheumatology Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held ...
|
|
|
